Published Paper Details:

Background: Non-Hodgkin's lymphoma (NHL) of the head of the neck is the proliferation of malignant neoplasms of the head and neck of the immune system and manifests into nodal and extranodal lymphomas. Objective : to report head and neck non-Hodgkin's lymphoma patients who received chemotherapy I in the Lotus Surgery Inpatient ENT-KL RSUD Dr. Soetomo. Methods: the data recorded included gender, age, tumor location, biopsy results, immunohistochemistry, chemotherapy regimens, side effects of chemotherapy. Result : The ratio of men and women is 1:1. The most tumor locations in tonsils, 8 patients (50.00%). Location in the nasal cavity, sinonasal and palate as many as 2 patients (12.50%). The location at least is in the hypopharynx and parotid, 1 patient (6.25%). The results of the biopsy showed a diagnosis of non-Hodgkin lymphoma in 10 patients (62.50%), suspicion of malignant round cell DD non-Hodgkin lymphoma differentiated carcinoma in 6 patients (37.50%). The use of chemotherapy regimens for patients with non-Hodgkin's lymphoma in the form of CHOP in 15 patients (93.75%) and the use of R-CHOP (Rituximab-CHOP) in 1 patient (6.25%). Conclusion: The number of male patients is the same as that of women with the highest age group being 41-70 years. The most common location for the tumor is the tonsils. Most of the tumor biopsy results showed non-Hodgkin's lymphoma without a differential diagnosis. Positive results of immunohistochemical examination were performed on NHL with the most differential diagnosis using cluster of differentiation 20. Chemotherapy regimens used were cyclophosphamide, doxorubicin, vincristine and prednisone with partial chemotherapy response. The most side effect of chemotherapy is a decrease in serum electrolytes